[Federal Register Volume 77, Number 160 (Friday, August 17, 2012)]
[Notices]
[Pages 49820-49821]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-20273]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of meetings of the 
National Center for Advancing Translational Sciences Advisory Council.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Cures Acceleration Network Review Board.
    Date: September 14, 2012.
    Time: 8:30 a.m. to 2:30 p.m.
    Agenda: Report from the Acting Institute Director.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 6, Bethesda, MD 20892.
    Contact Person: Jane A. Steinberg, Ph.D., Executive Secretary, 
National Center for

[[Page 49821]]

Advancing Translational Sciences, Bethesda, MD 20892, 301-443-3367.

    Name of Committee: National Center for Advancing Translational 
Sciences Advisory Council.
    Date: September 14, 2012.
    Open: 8:30 a.m. to 2:30 p.m.
    Agenda: Report from the Acting Institute Director.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 6, Bethesda, MD 20892.
    Closed: 3:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 6, Bethesda, MD 20892.
    Contact Person: Jane A. Steinberg, Ph.D., Executive Secretary, 
National Center for Advancing Translational Sciences, Bethesda, MD 
20892, 301-443-3367.

    Dated: August 13, 2012
Jennifer Spaeth
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-20273 Filed 8-16-12; 8:45 am]
BILLING CODE 4140-01-P